UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I II study

British journal of cancer, 2006-12, Vol.95 (11), p.1474-1482

2006

Volltextzugriff (PDF)

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

The Lancet (British edition), 1995-11, Vol.346 (8987), p.1399-1400

1995

Volltextzugriff (PDF)

Frameshift-Mutation-Derived Peptides as Tumor-Specific Antigens in Inherited and Spontaneous Colorectal Cancer

Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (23), p.13255-13260

2001

Volltextzugriff (PDF)

Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant

Experimental dermatology, 2001-06, Vol.10 (3), p.161-167

2001

Volltextzugriff (PDF)

Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

International journal of cancer, 2001-05, Vol.92 (3), p.441-450

2001

Volltextzugriff (PDF)

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21‐ras (12VAL) peptide vaccination of a patient, recognize 12VAL‐dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

International journal of cancer, 1997-09, Vol.72 (5), p.784-790

1997

Volltextzugriff (PDF)

Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccination

British journal of cancer, 1996-12, Vol.74 (11), p.1828-1833

1996

Volltextzugriff (PDF)

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study

International journal of cancer, 1996-02, Vol.65 (4), p.450-453

1996

Volltextzugriff (PDF)

Mutated Ras Peptides as Vaccines in Immunotherapy of Cancer

Vox sanguinis, 1998-06, Vol.74 (S2), p.489-495

1998

Volltextzugriff (PDF)

Combination of GM-CSF with antitumour vaccine strategies

European journal of cancer (1990), 1999-08, Vol.35, p.S33-S35

1999

Volltextzugriff (PDF)

Telomerase peptide vaccination : a phase I/II study in patients with non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2006-12, Vol.55 (12), p.1553-1564

2006

Volltextzugriff (PDF)

Generation and characterization of GP100 peptide-specific NK-T cell clones

International journal of cancer, 1998-03, Vol.75 (5), p.794-803

1998

Volltextzugriff (PDF)

Vanskelig - men viktig - med kritisk vurdering av ny teknologi

Tidsskrift for den Norske Lægeforening, 2009, Vol.129 (13), p.1355-1356

2009

Volltextzugriff (PDF)

A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

Cancer Immunology, Immunotherapy, 2001-11, Vol.50 (9), p.469-476

2001

Volltextzugriff (PDF)

A phase I/II study of telomerase peptide vaccination of patients with non-small cell lung cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2580-2580

2005

Volltextzugriff (PDF)

HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes

Journal of molecular medicine (Berlin, Germany), 2003, Vol.81 (1), p.43-50

2003

Volltextzugriff (PDF)

A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

Cancer immunology, immunotherapy : CII, 2001-11, Vol.50 (9), p.469-476

2001

Volltextzugriff (PDF)

A TGF beta RII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8 super(+) T cells

Cancer Immunology, Immunotherapy, 2001-11, Vol.50 (9), p.469-476

2001

Volltextzugriff (PDF)

Combination of GM-CSF with antitumour vaccine strategies: GM-CSF state of the art and future perspectives

European journal of cancer supplements, 1999, Vol.35 (3), p.S33-S35

1999

Volltextzugriff (PDF)

Optimization theory applied to dynamic biasing for power amplifier performance enhancement

2012 IEEE Topical Conference on Power Amplifiers for Wireless and Radio Applications, 2012, p.17-20

2012

Volltextzugriff (PDF)

Cytotoxic CD4 super(+) and CD8 super(+) T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

International journal of cancer, 1997-09, Vol.72 (5), p.784-790

1997

Volltextzugriff (PDF)

Biasing an HBT MMIC transistor for efficiency and output power enhancement

2012 Workshop on Integrated Nonlinear Microwave and Millimetre-wave Circuits, 2012, p.1-3

2012

Volltextzugriff (PDF)

First and second order polynomial functions for bandwidth reduction of dynamic biasing signals

2010 IEEE International Conference on Wireless Information Technology and Systems, 2010, p.1-4

2010

Volltextzugriff (PDF)

Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients

American journal of neuroradiology : AJNR, 2019-08, Vol.40 (8), p.1257-1264

2019

Volltextzugriff (PDF)

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

Blood, 2017-08, Vol.130 (6), p.789-802

2017

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I II study

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

Frameshift-Mutation-Derived Peptides as Tumor-Specific Antigens in Inherited and Spontaneous Colorectal Cancer

Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant

Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21‐ras (12VAL) peptide vaccination of a patient, recognize 12VAL‐dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccination

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study

Mutated Ras Peptides as Vaccines in Immunotherapy of Cancer

Combination of GM-CSF with antitumour vaccine strategies

Telomerase peptide vaccination : a phase I/II study in patients with non-small cell lung cancer

Generation and characterization of GP100 peptide-specific NK-T cell clones

Vanskelig - men viktig - med kritisk vurdering av ny teknologi

A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

A phase I/II study of telomerase peptide vaccination of patients with non-small cell lung cancer

HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes

A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

A TGF beta RII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8 super(+) T cells

Combination of GM-CSF with antitumour vaccine strategies: GM-CSF state of the art and future perspectives

Optimization theory applied to dynamic biasing for power amplifier performance enhancement

Cytotoxic CD4 super(+) and CD8 super(+) T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

Biasing an HBT MMIC transistor for efficiency and output power enhancement

First and second order polynomial functions for bandwidth reduction of dynamic biasing signals

Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

Suchergebnisse filtern